FDA Authorizes 24 Velo Nicotine Pouch Products

The agency greenlit the products for adult users as part of an effort to provide alternatives to combusted tobacco.

Updated on Oct. 30, 2026 in Substance Abuse

Isometric editorial illustration of a single small white cylindrical container, representing FDA-regulated nicotine pouch products in a minimalist clinical setting.
The FDA authorized 24 Velo nicotine pouch products under the premarket tobacco product application pathway to offer adult-only non-combusted alternatives. AI Illustration. Upload story photo >

Live Poll

Should the government authorize more nicotine pouch products as alternatives to traditional cigarettes?

The FDA has granted authorization to 24 Velo nicotine pouch products, including Mini Pouch and Mini Pouch 2 varieties. These items were approved through the agency's premarket tobacco product application pathway.

Why it matters

The authorization aims to provide adults aged 21 and older with access to non-combusted tobacco alternatives. Officials noted that these pouches contain lower levels of harmful constituents compared to traditional cigarettes.

Each authorized Velo pouch contains 4 milligrams of nicotine. The agency has now authorized 67 total nicotine pouches, following a review of the company's applications.

The players

Food and Drug Administration

The federal agency is responsible for protecting public health by regulating tobacco products, food safety, and medical devices.

Modoral Brands

This company is the manufacturer of the Velo line of nicotine pouches that recently received federal regulatory approval.

The details

Reviewers evaluated the products through the agency's nicotine pouch pilot program, confirming that the packaging includes required child-resistant features. The approval process focused on ensuring the items met regulatory standards for non-combusted alternatives.

Timeline

  1. The FDA issued the authorization for the 24 nicotine pouch products on October 30, 2026.

Health Landscape

This regulatory milestone follows the FDA's Premarket Tobacco Product Application (PMTA) pathway, which is designed to evaluate the public health impact of new tobacco products. The move reflects the agency's ongoing efforts to transition users toward less harmful non-combusted alternatives.

Adult users aged 21 and older will soon see these products on shelves with standardized child-resistant packaging. While these products contain less harmful constituents than cigarettes, they still deliver nicotine and are intended strictly for adult consumers.

The takeaway

The FDA continues to expand the list of authorized non-combusted tobacco options for adults while maintaining strict packaging safety requirements. Consumers should note that these products are not risk-free and are regulated under specific federal age restrictions.

Further reading

For more information on current federal regulations, visit the Substance Abuse section.

Source note: This article includes information reported by CStore Decisions.

Live Poll

Should the government authorize more nicotine pouch products as alternatives to traditional cigarettes?